Alfresa Holdings Corporation (JP:2784)

:2784

2784

Alfresa Holdings

RESEARCH TOOLSreports

Want to see JP:2784 full AI Analyst Report?

Alfresa Holdings (2784) Price & Analysis

0 Followers

2784 Stock Chart & Stats

¥2523.00

-¥11.50(-0.53%)

At close: Jan 08 4:00 PM EST

¥2523.00

-¥11.50(-0.53%)

Day’s Range― - ―

52-Week Range¥1,923.50 - ¥2,685.50

Previous CloseN/A

Volume412.80K

Average Volume (3M)354.02K

Market Cap

¥419.82B

Enterprise Value¥248.69B

Total Cash (Recent Filing)¥180.61B

Total Debt (Recent Filing)¥30.60B

Price to Earnings (P/E)9.6

Beta0.64

Next Earnings

Aug 11, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield2.69%

Share Statistics

EPS (TTM)150.82

Shares Outstanding191,300,000

10 Day Avg. Volume331,350

30 Day Avg. Volume354,016

Financial Highlights & Ratios

PEG Ratio0.20

Price to Book (P/B)0.91

Price to Sales (P/S)0.15

P/FCF Ratio28.53

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

¥2,400.00

Price Target Upside-4.88% Downside

Rating ConsensusHold

Number of Analyst Covering1

EPS Forecast (FY)155.59

Revenue Forecast (FY)¥3.19T

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetLow leverage and a stronger equity base provide durable financial flexibility for a distribution business that needs to hold inventory and fund working capital. This footing reduces default risk and supports strategic investments or M&A without pressuring cash flow in downturns.

Resilient Revenue GrowthConsistent, accelerating top-line growth indicates durable demand for core pharmaceutical distribution services. Stable revenue supports scale economics in logistics and purchasing, enabling long-term customer relationships and predictable planning for the networked supply model.

Scale And Logistics-driven ModelIntegrated wholesale, logistics and inventory capabilities create structural advantages: efficient order fulfillment, manufacturer relationships and clinic/pharmacy penetration. These operational strengths raise barriers to entry and sustain recurring distribution margins over time.

Bears Say

Very Thin Operating And Net MarginsExtremely narrow margins leave earnings highly sensitive to cost increases, reimbursement shifts or pricing competition. With limited margin buffer, small adverse changes can meaningfully reduce profitability and constrain reinvestment or dividend capacity over the medium term.

Inconsistent Cash ConversionVolatile operating cash and sporadic negative free cash flow reflect working-capital swings and timing effects. This undermines reliable internal funding for capex, acquisitions or shareholder returns and increases dependence on external liquidity management even with low leverage.

Modest Returns On CapitalROE remains moderate given the capital intensity of distribution. A large asset base combined with thin margins constrains the company's ability to convert revenue into attractive shareholder returns, limiting long-term capital efficiency and reinvestment upside.

Alfresa Holdings News

Alfresa Sets Terms for Japanese ASR-Linked Stock Acquisition Rights

The latest update is out from Alfresa Holdings ( ($JP:2784) ). Alfresa Holdings has set the terms for...

22d ago

Alfresa Completes ¥15 Billion Share Buyback to Boost Capital Efficiency

The latest update is out from Alfresa Holdings ( ($JP:2784) ). Alfresa Holdings has completed a ¥14.99 billion...

22d ago

ARHCF Earnings this Week: How Will it Perform?

Alfresa Holdings Corporation (ARHCF) is scheduled to report 4th quarter earnings on 05/19/2026. Regarding Q4 estimates, Wall Street...

23d ago

Alfresa Launches ¥15 Billion Share Buyback via Accelerated Repurchase

Alfresa Holdings ( ($JP:2784) ) has provided an update. Alfresa Holdings has approved a share repurchase of up...

25d ago

Alfresa to Shift Legal Public Notices From Newspaper to Digital Format

An announcement from Alfresa Holdings ( ($JP:2784) ) is now available. Alfresa Holdings will seek shareholder approval at...

25d ago

Alfresa Profit Jumps on Higher Sales as Outlook Turns Cautious for FY 2027

An announcement from Alfresa Holdings ( ($JP:2784) ) is now available. Alfresa Holdings reported consolidated net sales of...

25d ago

Alfresa Books ¥15.4 Billion Extraordinary Gain From Sale of Investment Securities

Alfresa Holdings ( ($JP:2784) ) has provided an update. Alfresa Holdings is a leading player in Japan’s healthcare...

4M ago

Alfresa Lifts Earnings, Keeps Guidance and Raises Dividend Despite Margin Pressure

Alfresa Holdings ( ($JP:2784) ) just unveiled an update. Alfresa Holdings reported consolidated net sales of ¥2.36 trillion...

4M ago

ARHCF Upcoming Earnings Report: What to Expect?

Alfresa Holdings Corporation (ARHCF) is scheduled to report 3rd quarter earnings on 02/10/2026. Regarding Q3 estimates, Wall Street...

4M ago

Alfresa Holdings Revises Fiscal 2025 Profit Forecast

The latest update is out from Alfresa Holdings ( ($JP:2784) ). Alfresa Holdings Corporation has revised its consolidated...

7M ago

2784 FAQ

What was Alfresa Holdings Corporation’s price range in the past 12 months?

Alfresa Holdings Corporation lowest stock price was ¥1923.50 and its highest was ¥2685.50 in the past 12 months.

What is Alfresa Holdings Corporation’s market cap?

Alfresa Holdings Corporation’s market cap is ¥419.82B.

When is Alfresa Holdings Corporation’s upcoming earnings report date?

Alfresa Holdings Corporation’s upcoming earnings report date is Aug 11, 2026 which is in 63 days.

How were Alfresa Holdings Corporation’s earnings last quarter?

Alfresa Holdings Corporation released its earnings results on May 15, 2026. The company reported ¥53.73 earnings per share for the quarter, beating the consensus estimate of ¥34.674 by ¥19.056.

Is Alfresa Holdings Corporation overvalued?

According to Wall Street analysts Alfresa Holdings Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Alfresa Holdings Corporation pay dividends?

Alfresa Holdings Corporation pays a Semiannually dividend of ¥35 which represents an annual dividend yield of 2.69%. See more information on Alfresa Holdings Corporation dividends here

What is Alfresa Holdings Corporation’s EPS estimate?

Alfresa Holdings Corporation’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Alfresa Holdings Corporation have?

Alfresa Holdings Corporation has 191,300,000 shares outstanding.

What happened to Alfresa Holdings Corporation’s price movement after its last earnings report?

Alfresa Holdings Corporation reported an EPS of ¥53.73 in its last earnings report, beating expectations of ¥34.674. Following the earnings report the stock price went up 2.06%.

Which hedge fund is a major shareholder of Alfresa Holdings Corporation?

Currently, no hedge funds are holding shares in JP:2784

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Alfresa Holdings Corporation

Alfresa Holdings Corporation, a Japanese company established in Tokyo in 2003, operates globally through its subsidiaries, specializing in the production, wholesale distribution, marketing, and international trade of pharmaceuticals, diagnostic reagents, and medical equipment. A significant part of its operations involves the wholesale supply of ethical pharmaceuticals, diagnostic reagents, and medical devices to healthcare providers including hospitals, clinics, and dispensing pharmacies. The company also manages the wholesale distribution of self-medication products, such as over-the-counter drugs, nutritional supplements, and health foods, to drugstores and pharmacies. Furthermore, Alfresa is engaged in the manufacturing and commercialization of active pharmaceutical ingredients, various pharmaceuticals, diagnostic reagents, and medical devices, alongside providing contract manufacturing services for pharmaceutical goods. Its medical-related division also encompasses the management of dispensing pharmacies and other associated healthcare activities.

Alfresa Holdings (2784) Earnings & Revenues

Historic Earnings Reports

2784 Stock 12 Month Forecast

Average Price Target

¥2,400.00

▼(-4.88% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1868":"¥1,868","2056":"¥2,056","2244":"¥2,244","2432":"¥2,432","2620":"¥2,620"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2400,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥2.40K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2400,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥2.40K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2400,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥2.40K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1868,2056,2244,2432,2620],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2163,2181.230769230769,2199.4615384615386,2217.6923076923076,2235.923076923077,2254.153846153846,2272.3846153846152,2290.6153846153848,2308.846153846154,2327.076923076923,2345.3076923076924,2363.5384615384614,2381.769230769231,{"y":2400,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2163,2181.230769230769,2199.4615384615386,2217.6923076923076,2235.923076923077,2254.153846153846,2272.3846153846152,2290.6153846153848,2308.846153846154,2327.076923076923,2345.3076923076924,2363.5384615384614,2381.769230769231,{"y":2400,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2163,2181.230769230769,2199.4615384615386,2217.6923076923076,2235.923076923077,2254.153846153846,2272.3846153846152,2290.6153846153848,2308.846153846154,2327.076923076923,2345.3076923076924,2363.5384615384614,2381.769230769231,{"y":2400,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1869.228,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1925.547,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2143.057,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2187.239,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2070.068,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2147.011,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2316.188,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2398.063,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2453.798,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2613.11,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2619,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2359,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2163,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >